Physician profile
Akshay Shah
NPI 1831119981
$319,446.15
in general payments reported to CMS, 2019-2025
8 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146K · 2020: $7,800 · 2021: $4,254 · 2022: $26K · 2023: $3,613 · 2024: $130K · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $77K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $36K · Travel and Lodging: $20K · Food and Beverage: $1,791 · Education: $47.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $77,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $35,630.00 |
| Travel and Lodging | $20,317.96 |
| Food and Beverage | $1,790.61 |
| Education | $47.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $114,600.89 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $91,432.47 | 2024 | |
| Shionogi INC | $56,314.12 | 2022-2025 | Fetroja |
| Insmed, INC. | $42,563.42 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $7,796.00 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $6,000.00 | 2020 | |
| Paratek Pharmaceuticals, INC. | $692.00 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $47.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.